We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Scintilla to Acquire SCILEX Pharmaceuticals

News   Aug 11, 2016

 
Scintilla to Acquire SCILEX Pharmaceuticals
 
 
 

RELATED ARTICLES

Using AI to ID Lung Cancer Types

News

A new computer program can analyze images of patients' lung tumors, specify cancer types, and even identify altered genes driving abnormal cell growth, a new study shows.

READ MORE

Characterizing the Function of Rare Tumor Cells

News

Scientists have long known that circulating tumor cells, rare cancer cells that are released into the bloodstream, have the potential to provide vital information about a person's specific cancer. Researchers have now created an effective mechanism to measure how these cells perform functions that drive the disease.

READ MORE

Altered Signaling Pathway in Cancer Controls Normal Kidney Development

News

Recent research finds that MAPK pathway, which is typically altered in many cancers, is required for regulation of normal renal differentiation during embryogenesis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE